Keep Me Logged In
Bill Ackman, founder and CEO of Pershing Square Capital Management, answers why he thinks Valeant's potential takeover of Allergan is beneficial, and the 'unprecedented' terms in the bid.
Got a confidential news tip? We want to hear from you.
Sign up for free newsletters and get more CNBC delivered to your inbox
© 2019 CNBC LLC. All Rights Reserved. A Division of NBCUniversal
Data is a real-time snapshot *Data is delayed at least 15 minutes. Global Business and Financial News, Stock Quotes, and Market Data and Analysis.
Data also provided by